Worldwide rare disease study led by Washington State University researchers Researchers Jean-Baptiste Roullet and Mike Gibson of the WSU College of Pharmacy and Pharmaceutical Sciences are conducting a natural history study of patients with succinic semialdehyde dehydrogenase deficiency (SSADHD). SSADHD is a genetic disorder that is [...]
Families affected by Segawa's disease perform their first meeting in Spain The Reina Sofía Hospital in Cordoba hosted the first meeting of families affected by Segawa's disease on Saturday, February 2. The meeting, organized by Neuropediatricians Eduardo López Laso and Joaquín A. Fernández Ramos, addressed the [...]
Relaunch of the iNTD website Walt Disney once said: "We keep moving forward, opening new doors, and doing new things, because we're curious and curiosity keeps leading us down new paths." We thought to do the same and take the new iNTD website online. You can [...]
Inherited Disorders of Neurotransmitters: Classification and Practical Approaches for Diagnosis and Treatment Neurotransmitter deficiencies are rare neurological disorders with clinical onset during childhood. The disorders are caused by genetic defects in the enzymes involved in synthesis, degradation, or transport of neurotransmitters or by defects in the [...]
Neurotransmitter deficiencies are rare neurological disorders with clinical onset during childhood. The disorders are caused by genetic defects in the enzymes involved in synthesis, degradation, or transport of neurotransmitters or by defects in the cofactor biosynthesis such as tetrahydrobiopterin (BH4). With the newly described DNAJC12 deficiency, a chaperon-associated neurotransmitter disorder, the pathophysiological spectrum has been [...]
Pregnancy management and outcome in patients with four different tetrahydrobiopterin disorders Introduction Inborn errors of tetrahydrobiopterin (BH4) biosynthesis or recycling are a group of very rare neurometabolic diseases. Following growing awareness and improved availability of drug treatment the number of patients with BH4 disorders reaching adulthood [...]
Annual Meeting of the SSADH Defizit e.V. On the 19th of May 2018 the SSADH Defizit e.V. hold it´s annual meeting in Cologne. Participates were informed about the ongoing activities, offered advice on social matters and research topics that are supported by the association were presented. [...]
Das 2. Treffen der Patienten-/ Eltern Vereinigung „Fachgruppe Neurotransmitterstörung“ unter dem Dachverband DIG PKU (Deutsche Interessengemeinschaft Phenylketonurie) findet am Samstag, den 30.06.2018 von 14:00 Uhr bis 16:10 Uhr in Heidelberg statt. https://www.dig-pku.de/calendar/index.php?event/106-2-treffen-der-fachgruppe-neutransmitterst%C3%B6rungen-in-der-universit%C3%A4tsklinik-heide/ Eine Teilnahme ist auch ohne Mitgliedschaft im Verein möglich. Wer teilnehmen möchte, wendet sich bitte an den Ansprechpartner Kai Meuer (This email address is being [...]
The first parent and patient organization within Germany for disorders that are affecting the neurotransmitter metabolism was founded recently within the framework of the DIG PKU. The group aims to improve the situation of families affected by these rare diseases and to bring them together for an exchange of their experiences. The group can be [...]
Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency. Aromatic L-amino acid decarboxylase deficiency (AADCD) is a rare, autosomal recessive neurometabolic disorder that leads to a severe combined deficiency of serotonin, dopamine, norepinephrine and epinephrine. Onset is early in life, and [...]
